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1.  Introduction 
 
Leishmaniasis is a parasitic disease caused by the genus Leishmania; these 
protozoa are transmitted by sandflies of genus Phlebotomus or Lutzomyia, which are 
commonly found in tropical and subtropical regions of the planet (1,2). Different 
Leishmania species are responsible for the three distinct clinical manifestations of 
leishmaniasis: cutaneous leishmaniasis (where self-healing skin lesions and often 
disfugurement of the skin occurs), mucocutaneous leishmaniasis (where the parasites 
affect the mucous membranes of the mouth and nose) and the most serious of the three 
diseases, visceral leishmaniasis (where the parasites infect the liver and spleen).  Of all 
three variations, visceral leishmaniasis has the most debilitating effect because it affects 
the immune system and is often fatal if left untreated. Leishmaniasis currently affects 12 
million people in 88 countries in which 80% are developing countries, making treatment 
a severe health problem (3).  Because of the effect leishmaniasis has on humans and 
society, it is necessary to develop drugs that adequately treat and prevent the disease. 
 The current antileishmanial drugs have several limitations such as their route of 
administration (injection), toxicity and cost (4). There has also been a growing resistance 
to the first-line antimony-containing drugs currently available against leishmaniasis, 
making it necessary to develop new drugs that are orally available, inexpensive, and safe 
with short-term treatment.  Pentamidine (Figure 1) is one of the few antileishmanial drugs 
currently available.  It belongs to the diamidine class of drugs, which has been suggested 
to exert antiparasitic activity by binding to DNA, interfering with polyamine metabolism 
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and disrupting of mitochondrial membrane potential (5).  Previous work concerning 
pentamidine suggests that the drug is taken up by saturable transport process in 
Leishmania, but the function of the transporter is still unknown (6).  It also suggests that 
pentamidine causes damage to the mitochondrion of Leishmania as observed using 
electron microscopy (8,9).  The clinical use of pentamidine is limited by its toxicity, 
administration by injection and development of resistance (7).  Our laboratory is involved 
with the evaluation of pentamidine analogs as new antileishmanial drug candidates.  
Collaborators at Georgia State University synthesized two classes of compounds based 
on pentamidine: the diamidines DB111, DB1213, DB1282 and DB1288 and the reversed 
diamidines DB702, DB709 and DB746 (see Figure 1 for the structures of pentamidine, 
DB1288, and DB746).  These compounds show excellent in vitro antileishmanial 
activity, but their mechanism of antiparasitic activity is unknown.  If the mechanism of 
action of these agents could be determined, we may be able to design more active 
compounds that work in the same way and avoid toxic effects in the host.   
 The purpose of this work is to test the hypothesis that these two classes of 
compounds are toxic to Leishmania by interfering with the parasite mitochondrion.  To 
test this hypothesis, I planned to determine the IC50 values of the seven compounds 
against Leishmania donovani promastigotes, conduct mechanism of action studies 
employing flow cytometry and electron microscopy, and generate parasites resistant to 
one or more of these compounds in an effort to test this hypothesis. 
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Figure 1. Structures of the named compounds 
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2.  Methods 
 
2.1 Determining IC50 values against L. donovani axenic promastigotes.  
 
L. donovani promastigotes were grown in vitro at 25 °C in modified RPMI 1640 
medium with 25 mM HEPES and supplemented with 10 % heated inactivated 
fetal bovine serum (FBS), 0.2 mM glutamine, 0.1 mM adenosine, 1 µg/mL of 
folate, 50 units/mL of penicillin, 50 µg/mL of streptomycin and 1 x RPMI 1640 
vitamins.  L. donovani promastigotes at 106 parasites/mL were plated in a 96-well 
plate with 2-fold serial dilutions of the seven compounds mentioned above and 
pentamidine.  Plates were incubated for 3 days at 25 °C, and then the CellTiter 
reagent, a tetrazolium indicator dye, was added for 3-4 hours to measure the cell 
viability.  The drug concentration at which 50% of the parasites were inhibited 
compared to control (the IC50 value) was determined using spectrophotometric 
detection at 490 nm using the four parameter curve equation available in the plate 
reader software. 
2.2 Flow Cytometry 
L. donovani promastigotes at a cell density of 5x106cells/mL were incubated with 
pentamidine, DB1288 and DB746 at their IC50 concentrations and 10x their IC50 
concentrations for 24 h at 25 °C.  1 x 107 parasites were collected and centrifuged 
at 1200 x g for 10 min at RT.  The supernatant was removed from samples and the 
pellet was resuspended in 100 µL of 0.1 mM MitoTracker Green FM (MTG) 
solution for 3-4 h at 25 °C.  The parasites were then fixed with 400 µL of 4% 
formaldehyde in promastigote medium for 15 min at 25 °C.  The cells were then 
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centrifuged as before and resuspended in 1 mL PBS and analyzed by flow 
cytometry. 
2.3 Transmission Electron Microscopy  
L. donovani promastigotes at 5x106cells/mL were incubated with pentamidine at 
10 µM, DB1288 at 2.5 µM and DB746 at 0.2 µM, all at 5x the IC50 
concentrations, for 24 h at 25 °C.  Samples were centrifuged for 10 min at 3200 x 
g at 4 °C and resuspended with 1 mL of fixative (4% paraformaldehyde, 0.1M 
sucrose in 0.1 M phosphate buffer) for 3 h at room temperature.  The cells were 
rinsed 4x with 0.1 M phosphate buffer containing 0.1 M sucrose then incubated 
for 1 h with 1% osmium tetroxide in buffer, rinsed twice and resuspended in 2% 
agarose and chilled in an ice bath for 10 min to set the agarose.  The agarose was 
cut into 1 mm blocks and stained with 2% aqueous uranyl acetate for 1 h, and 
then rinsed 3x with distilled water, then dehydrated in graded percentages of 
ethanol for 10 min at 50% - 100%.  The cells were then treated with propylene 
oxide alone for 10 min, then propylene oxide with spur resin (1:1 for 1 h, and then 
1:2 overnight) and then embedded in spur resin and polymerized overnight at 60 
°C.  Ultrastructural analysis was performed on a Philips CM 12 transmission 
electron microscope (STEM). 
2.4 Generation of parasites resistant to DB1288  
Wild-type cells were cultured in the presence of 0.4 µM DB1288 with an increase 
of 0.2 µM in drug pressure every four weeks to 1 µM and then a final increase in 
drug pressure to a concentration of 2 µM, at which the culture was stabilized for 9 
months at one passage per week. 
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2.5 Studies with parasites resistant to DB1288 
Wild-type and DB1288 resistant L. donovani promastigotes were plated at a 
density of 106 parasites/mL on a 96-well plate with 2-fold serial dilutions of 
DB1288, DB746 and pentamidine.  Plates were incubated for 3 days at 25 °C, and 
then the CellTiter reagent was added for 3-4 h to measure the cell viability.  IC50 
values were determined by addition of the Cell Titer reagent followed by 
spectrophotometric detection at 490 nm as described earlier. 
3. Results 
 
3.1 Activity of Compounds against L. donovani promastigotes 
Table 1 shows the results of the activity of the seven compounds plus pentamidine 
against L. donovani promastigotes. All seven compounds had excellent 
antileishmanial activity and some of the reversed diamidines showed over 10-fold 
greater activity against the parasites compared to the diamidines.  Subsequent 
experiments were restricted to one agent from each class of compounds: the 
diamidine DB1288 and the reversed diamidine DB746, which was the most potent 
of the seven compounds.  The IC50 values for DB1288 and DB746 were 0.56 µM 
± 0.12 and 0.030 µM ± 0.01 respectively (values given as the mean ± standard 
deviation of three independent measurements). 
3.2 Measurement of MitoTracker Green Fluorescence 
MitoTracker Green FM (MTG), a fluorescent molecular probe that localizes in the 
parasite mitochondrion, was employed to determine any mitochondrial membrane 
potential alterations caused by the compounds.  Previous work on pentamidine 
has shown a collapse in mitochondrial potential when Leishmania parasites were 
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treated with this compound (5).  From the results in Table 2, pentamidine at a 
concentration of 2 µM for 24 h didn’t show any significant decrease in 
fluorescence but at 10x the IC50 value, 20 µM for 24 h, there was a decrease in 
fluorescence but not as pronouced as in previous reports.  DB1288 at 10x the IC50 
concentration, 5 µM for 24 h, showed a decrease in fluorescent of roughly 47%, 
suggesting that this diamidine affects the mitochondrial potential.  DB746 at the 
IC50 concentration and 10x the IC50 concentration for 24 h didn’t show a 
significant decrease in MTG fluorescence, suggesting a different route of toxicity 
on the parasites. 
3.3 Transmission Electron Microscopy (TEM) 
Morphological changes in the parasites after treatment with the named 
compounds were observed using TEM (Figure 2).  Previous work on the 
antileishmanial effect of pentamidine with TEM has revealed disintegration of the 
kinetoplast and mitochondrion (8,9).  In Figure 2, DB746 at 5x the IC50 
concentration, 0.2 µM for 24 h, did not show significant morphological alterations 
to the nucleus.  What was observed in roughly 50% of the sample was 
disintegration of the cytoplasm, an intact cellular membrane and nucleus and in 
some cases an intact mitochondrion.  In DB1288 at 5x the IC50 concentration, 2.5 
µM for 24 h, a significant effect on the mitochondrial membrane was observed.  
In roughly 80% of the sample, the kinetoplast DNA was less intense compared to 
the control, and significant disintegration and dilation of the mitochondrion was 
observed. 
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3.4 Cross resistance studies 
We measured the IC50 values of wild-type parasites and organism resistant to 
DB1288 at 2 µM (4x IC50 value), see Table 3 for results.  We observed a 7-fold 
increase in the IC50 value of pentamidine, a 28-fold increase in IC50 value of 
DB1288 and 3.6-fold increase in IC50 value of DB746. 
 
4.  Discussion 
The results obtained with DB1288 support the hypothesis that this 
diamidine interferes with the parasite mitochondrion.  Disintegration and dilation 
of the mitochondrion occurs in Leishmania treated with DB1288, also causing 
degradation of the kinetoplast DNA compared to the control in TEM micrographs 
and a possible dilation of the mitochondrion, which winds throughout the cell in 
Figure 2H and G.  We also observed a significant decrease in MitoTracker Green 
fluorescence in parasites exposed to DB1288, indicating that DB1288 alters the 
mitochondrial membrane potential in Leishmania.  We also discovered that 
DB1288 localized in the nucleus and kinetoplast of Leishmania, although we 
could not obtain high quality micrographs to demonstrate this.  Previous work 
with the fluorescent diamidine DAPI on Leishmania has revealed its localization 
in the parasite nucleus and kinetoplast DNA (11).  The results from the studies in 
Table 3 show that the DB1288 resistant parasites are cross-resistant to 
pentamidine, consistent with a common mechanism of action for the two 
diamidines.  This result is similar to a published paper in which pentamidine 
resistant L. donovani expressed cross-resistance to other diamidines (10). 
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Effects of DB746 were more difficult to demonstrate.  From the flow 
cytometry experiments in measuring MitoTracker Green fluorescence, it is 
questionable to suggest that DB746 interferes with mitochondrial membrane 
potential as was observed from the results in Table 2.  Also, the micrographs from 
TEM suggest that DB746 exerts its antileishmanial activity by altering the 
cytoplasm of the parasites and in a few cases by dilating of the parasite 
mitochondrion membrane as observed in Figure 2C.  We also observed from the 
results in Table 3, that DB746 showed only a 3.6-fold increase in the IC50 value 
compared to DB1288 (28-fold increase) and pentamidine (7-fold increase).  
Taken together these results suggest an additional mechanism of antileishmanial 
activity for DB746. 
Further studies into the mechanism of action of these agents are needed to 
adequately design more active compounds against Leishmania parasites that have 
non-toxic effects in the host.  Such studies include examining MTG fluorescence 
in resistant and control parasites as a measure of membrane potential and carrying 
out electron microscopy and MTG experiments on L. donovani exposed to lower 
concentrations of DB746 
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TABLE 1 Activity of compounds against wild-type L. donovani promastigotes 
 
Compound Average IC50 ± error (µM)* 
Pentamidine  1.5 ± 0.56 
DB1312 0.89 ± 0.31 
DB1111 2.3 ± 0.60 
DB1282 0.16 ± 0.04 
DB1288 0.56 ± 0.12 
DB709 0.32 ± 0.07 
DB702 0.036 ± 0.01 
DB746 0.030 ± 0.01 
*IC50 values represent the mean ± standard error of at least three independent measurements  
 
 
 
TABLE 2 Analysis of MitoTracker green fluorescence in L. donovani 
promastigotes 
 
                Compounds % Decrease in Fluorescence Intensity 
compared to control 
Pentamidine, 2µMb 3.4 
Pentamidine, 20µMa 22 ± 12 
DB1288, 0.5µMa 12 ± 5 
DB1288, 5µMa 47 ± 7 
DB746, 0.04µMa 7.9 ± 5.9 
DB746, 0.4µMa 16 ± 11 
aFlow cytometry results represent the mean ± standard error of at least three independent measurements 
bFlow cytometry result represents one independent experiment 
 
 
 
TABLE 3 Activity of compounds against resistant DB1288 at 2 µM L. donovani 
promastigotes 
 
Compounds Average IC50 ± error (µM)* 
Pentamidine      14 ± 3 
DB1288      14 ± 4 
DB746      0.11 ± 0.05 
*IC50 values represent the mean ± standard error of at least five independent measurements  
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A. Control-1 
 
B. Control-2 
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C. DB746-1 
 
 
 
 
 
D. DB746-2 
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E. DB746-3 
 
 
F. DB1288-1 
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G. DB1288-2 
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H. DB1288-3 
 
 
 
 
Figure 2. Transmission electron micrographs of L. donovani promastigotes for 24 h of 
Controls (2 graphs), DB1288 at 2.5 µM (3 graphs) and DB746 at 0.2 µM (3 graphs) 
 
 
 
